Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis

1 Nov 2021

Abstract excerpt

BACKGROUND: Exportin 1 (XPO1), a nuclear export protein, participates in many biological processes, including mRNA transport, nucleocytoplasmic transport, nuclear protein export, regulation of mRNA stability, and drug response. XPO1 plays key roles in many cancer types and may serve as a potential biomarker. It is significant to systematically elucidate the roles of XPO1 in various cancer types in terms of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Genetic factors in colorectal cancer
Share to Nuclear Structure and Function

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35116322
DOI: 10.21037/tcr-21-1646

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesisPMID 35116322Read ↗

Targeting XPO1-Dependent Nuclear Export in Cancer.Semantic proximity Read ↗

Impact of Pan-Cancer Analysis of The Exportins Family on Prognosis, The Tumour Microenvironment and Its Potential Therapeutic EfficacySemantic proximity Read ↗

Identification of EXO1 as a potential biomarker associated with prognosis and tumor immune microenvironment for specific human cancers.Semantic proximity Read ↗

XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.Semantic proximity Read ↗

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).Semantic proximity Read ↗

Less immune cell infiltration and worse prognosis for NSCLC patients with XPO1 copy number alterationsSemantic proximity Read ↗

XPO1 R749Q Mutations Co-occur with POLE Mutations in Cancer and Can Be Targeted to Overcome Chemoresistance.Semantic proximity Read ↗

Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinomaSemantic proximity Read ↗

XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.Semantic proximity Read ↗

The past, present, and future of CRM1/XPO1 inhibitorsSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.Semantic proximity Read ↗

Multi-level systems analysis identifies XPO1 as a druggable target linked to NFκB activation, proliferation, tumor clonality and long-term survival in Adult T-cell LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.